(bio)Pharma Ireland was formed in 2015 as an SSPC initiative to highlight the collective research priorities and industrial capabilities of the Irish (bio)Pharmaceutical sector within the European community; encourage research collaborations and opportunities; and ultimately contribute to the development of European policy.
The working group, coordinated and chaired by the SSPC, has representation from pharmaceutical industry including Biopharmachem Ireland (BPCI), government agencies: Science Foundation Ireland, Enterprise Ireland and the IDA; and academic research organisations: the Synthesis and Solid State Pharmaceutical Centre (SSPC), National Institute for Bioprocessing Research and Training (NIBRT) and the Pharmaceutical Manufacturing and Technology Centre (PMTC).
Chris Edlin, Jon O'Halloran and Killian O'Driscoll pictured in Brussels earlier this year.
(bio)Pharma Ireland is organising a high-level seminar entitled “The Future of (Bio)Pharmaceutical Manufacturing”,
which will take place on 28 February 2017 in Thon Hotel EU (Rue de la loi 75, 1040 Brussels).
Exploring advanced drug manufacturing from the perspective of research organisations and industry, the seminar will address the enabling policy and regulatory environment required for innovative pharmaceutical and biopharmaceutical manufacturing process that would support quality healthcare delivery in Europe. The seminar’s objective is to bring together policy- and decision-makers, industry R&D and academia, and other relevant stakeholder organizations in order to discuss a roadmap for innovation in (bio)pharmaceutical manufacturing.
To attend please register here
For further information, please contact:
Declan Kirrane, Managing Director, ISC
Tel: + 32 494 34 60 40
Tjaša Petročnik, Policy Analyst, ISC
Tel: +32 2 880 36 24
Working Group Representatives: